Published: 24-Sep-2020 | Published By: Market Research Store
For low blood sugar levels, metformin is the first-line medicationthat is prescribed to the type 2 diabetes sufferers. However, studies have shown one third of the subjects to not react to metformin treatment and around 5% patients to experience severe side effects. Thus, the use of is medication is majorly avoided by both doctors and the patients. But, the researchers from the Lund University have spotted biomarkers that can beforehand show the patient’s response to metformin treatment through a self-effacing blood test. The fundamental goal is to achieve personalized care for diabetes patients for ensuring that the right individual gets the right treatment or care immediately after the diagnosis.
There are times when even diet and exercising seem insufficient in regulating the blood sugar levels and thus, here is where metformin comes as the first line of drug introduced to treat type 2 diabetes. Moreover, this drug is the first one introduced as per the international guidelines to treat type 2 diabetes. The intended effects of metformin as made patients look for other alternative drugs to lower their blood sugar levels. As the correct treatment is not received at the right time there are chances of more complications occurring due to the elevated levels of blood sugar.
Most cumbersome task for the medical professionals is to allotting the right medication to individual as per the responding levels and thus, it is important that patient’s undergo proper diagnosis for better outcome. The researchers have found the epigenetic factors, such as DNA methylation, to have the potential to be used as biomarkers to analyze the effect of a drug. It is the first time, the pharmacoepigenetics that is usually used in cancer treatment to predict an individual’s response to treatment will be used in diabetes care. The DNA methylations will help understand the body response to the diabetic drug and thereby advance personalized therapy in type 2 diabetes.
Market Research Store has published a report on global metformin industry market. The report introduces the industry chain structure, market valuation, latest developments, competitive landscape, regional distribution, pricing, and future trends of the metformin market.
Global Milk Packaging Market Report 2020 - Industry Research Report
Global Insulin Delivery Devices Market Report 2020 - Industry Analysis Size Share Trends Segment and Forecasts to 2025 (Based on 2020 COVID-19 Analysis)
Global Fuel Burner Market Report 2020 - Industry Analysis Size Share Trends Segment and Forecasts to 2025 (Based on 2020 COVID-19 Analysis)
Global Aerospace Segment Market Report 2020 - Industry Analysis Size Share Trends Segment and Forecasts to 2025 (Based on 2020 COVID-19 Analysis)
Global Low-Code Business Process Management (BPM) Market Report 2020 - Industry Analysis Size Share Trends Segment and Forecasts to 2025 (Based on 2020 COVID-19 Analysis)View More
Low-Priced, Tiny Chip Sats Can Make Space Launch Cheaper
The Cornell Universitys PhD student Zac Manchester had imagined about developing chip-scale satell
Researchers Build A Biosensor Similar To That Of Our Nose
Human nose is found to have the potential of differentiating trillion types of odor using the 400
Researchers Are Working Toward Building Smart Plastics
Smart packaging could actually help increase the shelf life of the packed products. Furthermore, i
Meditation And Yoga Could Be The New Treatment To Relieve Pain
People dealing with chronic pain and depression are generally advised by the medical professionals
Eyeglasses Are Predicted To The Fourth Defensive Measure Against Coronavirus
Wearing masks has turned into a trend during this COVID-19 pandemic. However, it is not just the m